RxDoctor Payments Data

Vicki Lary

Family · Greenwood, MSNPI 1083788665

Payments from drug & device makers

$2,460in general payments, 2019–2025

Across 137 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$697
  • Lilly USA, LLC$419
  • Abbott$260
  • GSK$231
  • Novo Nordisk$216
  • Pfizer$188
  • plus $450 from 10 others

What the payments were for

  • Food & beverage$2,460100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,460 in reported general payments places this provider in the 80th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$58,346
Medicare patients
282
Services billed
1,497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide53$51,208
MounjaroTirzepatide32$31,088
FarxigaDapagliflozin Propanediol48$30,355
EliquisApixaban42$29,199
JardianceEmpagliflozin41$27,892
TrulicityDulaglutide21$22,822
LinzessLinaclotide21$17,874
XareltoRivaroxaban22$11,471
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$10,766
Tresiba Flextouch U-100Insulin Degludec14$8,622
Breo ElliptaFluticasone/Vilanterol11$4,405
SynthroidLevothyroxine Sodium94$4,198
PremproEstrogen,con/M-Progest Acet13$3,089
Gabapentin198$2,696
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$2,693

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$419$53,91053 claims
Novo NordiskOzempic$216$51,20853 claims
PfizerEliquis, Prempro$188$32,28955 claims
AstraZenecaFarxiga$697$30,35548 claims
Boehringer IngelheimJardiance$27$27,89241 claims
AbbVieLinzess, Synthroid$116$22,072115 claims
GSKTrelegy Ellipta, Breo Ellipta$231$15,17028 claims
Johnson & JohnsonXarelto$13$11,47122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,007 family providers in Mississippi.

Other family in Greenwood

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →